Cold & Cough Remedies (Pharmacies) - Switzerland

Revenue in the Cold & Cough Remedies market is projected to reach US$104.70m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.61%, resulting in a market volume of US$131.20m by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$11.83 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in Switzerland has been steadily growing in recent years.

Customer preferences: Swiss customers have shown a strong preference for over-the-counter cold and cough remedies purchased from pharmacies. This is due to the convenience and accessibility of pharmacies, as well as the trust and confidence that customers have in the quality and effectiveness of these products. Swiss consumers value their health and are willing to invest in remedies that can provide relief from cold and cough symptoms.

Trends in the market: One of the key trends in the Cold & Cough Remedies market in Switzerland is the increasing demand for natural and herbal remedies. Swiss consumers are becoming more health-conscious and are seeking products that are perceived as more natural and less likely to have side effects. This has led to a rise in the popularity of herbal remedies that are believed to boost the immune system and alleviate cold and cough symptoms. Another trend in the market is the growing demand for combination products that offer multiple benefits. Swiss consumers are looking for remedies that can address multiple symptoms at once, such as relieving congestion, soothing a sore throat, and reducing coughing. Combination products that offer these benefits in a single dose have gained popularity in the Swiss market.

Local special circumstances: Switzerland has a high standard of healthcare and a strong pharmaceutical industry. The country is known for its high-quality healthcare services and products, which has contributed to the trust that Swiss consumers have in over-the-counter remedies purchased from pharmacies. Additionally, Switzerland has a well-developed pharmacy network, with pharmacies easily accessible in both urban and rural areas. This accessibility has further fueled the growth of the Cold & Cough Remedies market in the country.

Underlying macroeconomic factors: The growing Cold & Cough Remedies market in Switzerland can be attributed to several underlying macroeconomic factors. Firstly, the country has a high per capita income, allowing consumers to afford healthcare and pharmaceutical products. Secondly, Switzerland has an aging population, which is more susceptible to cold and cough symptoms and therefore has a higher demand for remedies. Lastly, the country has a strong healthcare system that emphasizes preventive care and encourages individuals to seek early treatment for cold and cough symptoms, driving the demand for remedies. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Switzerland is experiencing growth due to customer preferences for over-the-counter remedies, the increasing demand for natural and combination products, the accessibility of pharmacies, Switzerland's high standard of healthcare, and underlying macroeconomic factors such as high per capita income and an aging population.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.